What is AST?
AST specializes in providing advanced aseptic filling and closing systems, catering to the pharmaceutical and biotechnology industries. With decades of experience, the company offers innovative and flexible solutions designed to meet stringent product and regulatory requirements. Their product lineup includes integrated fill-finish systems, aseptic processing solutions, and various container filling technologies. AST aims to serve clients involved in drug development, biologics manufacturing, cell and gene therapy, and compounding pharmacies. The company's focus on precision and compliance positions it as a key partner for life science organizations requiring sterile manufacturing environments.
How much funding has AST raised?
AST has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in AST
PPP
Public-Private Partnership
What's next for AST?
The recent strategic investment of $350K positions AST for accelerated expansion and technological advancement. As a company operating in the large-scale late-stage funding environment, AST is likely to focus on scaling its manufacturing capabilities, enhancing its R&D pipeline for next-generation aseptic technologies, and potentially broadening its market reach through strategic partnerships or acquisitions. The capital infusion will be instrumental in solidifying its competitive edge and meeting the increasing global demand for high-quality pharmaceutical manufacturing solutions, particularly in areas like biologics and advanced therapies.
See full AST company page
